You are here: Industry Insights > Pharma in China

News List

Sales of Zai Lab’s PARP Inhibitor Reaching RMB46.90 Million in Macau, S.A.R., China and Hong Kong, S.A.R., China of China in 2019 PharmaSources/Caicai
March 31, 2020
According to the 2019 results and company progress released by Zai Lab on Mar. 19, the total sales revenue of niraparib (trade name: Zejula) reached USD6.60 million (around RMB46.90 million) in Hong Kong, S.A.R., China and Macau, S.A.R., China Region of C
Industrial Layout Analysis of the New Candidate Drug Against COVID-19: Sivelestat Sodium PharmaSources/Zhulikou431
March 20, 2020
The NMPA has so far urgently approved the clinical trials of 5 products against the COVID-19 to better prevent and control it, including sivelestat sodium hydrate, favipiravir, remdesivir, and BDB-001 injection, etc.
NASH: Seizing The USD40-Billion NASH Drug Market PharmaSources/Caicai
March 19, 2020
The global NASH drug market will reach USD40 billion by 2025. Such a huge market is in urgent need of blockbusters.
HCC Therapeutic Regimens Rewritten by Tumor Immunotherapies: the 12 Years from Sorafenib to Tumor Immunotherapies PharmaSources/1℃
March 18, 2020
Opdivo kicked off the era of HCC immunotherapies in the world, and AiRuiKa’s taking the lead in receiving the approval for HCC indication in China was an important milestone!
Quick Look at the Anti-epidemic Monoclonal Antibodies that Target the Novel Coronavirus S Protein PharmaSources/Xiaoyaowan
March 17, 2020
The General Office of the National Health Commission and the Office of the National Administration of Traditional Chinese Medicine of China issued the COVID-19 Diagnosis and Treatment Scheme (Trial Version 6) on Feb. 19. It's worth noting that the scheme
Yichang Humanwell’s Class 3 Generic Drug Alfentanil Hydrochloride Approved for Marketing PharmaSources/Caicai
March 16, 2020
The drug becomes one of the first alfentanil drugs approved for marketing in China. Alfentanil Hydrochloride Injection is a potent analgesic used for anesthesia and applies to short surgical procedures.
Oral Vaccines: A New Drug Development Area that Must be Paid Attention to under the COVID-19 Epidemic PharmaSources/Miling
March 10, 2020
The “oral vaccines” that can produce mucosal immunity must be an effective way to control the novel coronavirus and also hepatitis C, hepatitis B, human papilloma virus, and influenza virus, etc.
Which Will Claim the Real "Magic Medicine" Among 3 "Specific Medicines" against Novel Coronavirus Pneumonia PharmaSources/Mi Ling
February 25, 2020
Challenge Contest of "Specific Medicines" against Novel Coronavirus Pneumonia - Which Will Claim the Real "Magic Medicine" in Such 1/3 Competition?
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (2) PharmaSources/Zhulikou431
February 14, 2020
The collection time of the information summarized above is Feb. 2, 2020, which will change with the progress of scientific research.
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (1) PharmaSources/zhulikou431
February 14, 2020
The novel coronavirus pneumonia incident that started to occur in Wuhan City, Hubei Province from Dec. 2019 has produced continuous impacts on the Chinese people.